Search clinical trials for: Antiretroviral Therapy Interruption(ATI)

Total 4052 results

American Gene Technologies International Inc.

Enrolling by invitation

An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy

HIV

United States
Hospital Clinic of Barcelona

Completed

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

HIV-Associated Lipodystrophy Syndrome

Spain
Rockefeller University
National Institute of Allergy and Infectious Diseases (NIAID); Montefiore Medical... and other collaborators

Completed

A Study of the Safety and Antiretroviral Activity of 3BNC117

HIV-1 Infection

United States
Objectif Recherche Vaccins SIDA
Fondation Bettencourt-Schueller

Completed

Towards HIV Functional Cure (ULTRASTOP)

Chronic HIV-1 Infection

France
National Institute of Allergy and Infectious Diseases...

Withdrawn

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Withdrawn

Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV

HIV Infections
ETOP IBCSG Partners Foundation
Alliance for Clinical Trials in Oncology; Canadian Cancer Trials Group; Breast...

Active, not recruiting

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE)

Early Breast Cancer

Korea, Republic of, United States, France, Canada, Spain, Lebanon, Belgium, Switzerland, Israel, Ireland, Japan, Italy, Denmark, Austria, Australia, Greece, Hungary, Netherlands, Norway, Portugal, Serbia, Slovenia
Tel-Aviv Sourasky Medical Center

Unknown

Structured Treatment Interruption (STI) in Acute/Primary HIV

HIV Infections
Rockefeller University

Completed

3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption

HIV-1 Infection

United States
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Understanding the Increased Risk of Cardiovascular Disease in People With HIV

HIV Infections
ANRS, Emerging Infectious Diseases

Recruiting

Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 Genotype

HIV Infections

France
University of California, San Francisco
Universitywide AIDS Research Program

Completed

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

HIV Infections

United States
Centers for Disease Control and Prevention
The AIDS Support Organization; British Medical Research Council

Completed

Comparison of Facility and Home-based ART Delivery Systems in Uganda

AIDS

Uganda
Rockefeller University
Aaron Diamond AIDS Research Center

Completed

Observational Study of Treated and Untreated Acute and Early HIV-1 Infection

HIV Infections

United States
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

HIV

Portugal
National Center for Research Resources (NCRR)
Elizabeth Glaser Pediatric AIDS Foundation

Completed

The Metabolic Effects of Protease Inhibitors in HIV Infected Children

HIV Infections

United States
Hospices Civils de Lyon

Completed

Impact of CMV Status on HIV Viral Load Decay

Hiv

France
University of Washington
National Institute of Mental Health (NIMH)

Recruiting

HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV (HeadStART)

HIV Infections | Hiv

Uganda
Peking Union Medical College Hospital

Completed

Gut Microbiota Changes of HIV Patients Before and After One Year of ART

HIV Infections

China
Duke University
Janssen, LP

Completed

Obesity in HIV After Antiretroviral Therapy

Obesity | HIV | AIDS

United States
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection (VIRECURE)

HIV Infections

Spain
Yale University

Completed

Directly Observed Therapy for Community-Released HIV+ Prisoners (Connect)

HIV/AIDS | Substance Abuse

United States
Yale University

Completed

Directly Observed Antiretroviral Therapy Among Active Drug Users

HIV/AIDS | Substance Abuse

United States
Botswana-UPenn Partnership
University of Pennsylvania; Doris Duke Charitable Foundation

Completed

Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis (Crypto)

HIV Infections | Cryptococcal Meningitis

Botswana
Johns Hopkins Bloomberg School of Public Health
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Anti-HIV Medications for People Recently Infected With HIV

HIV Infections

United States, Canada
International Maternal Pediatric Adolescent AIDS...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy...

Completed

IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women

HIV Infection

United States, Argentina, Botswana, Brazil, China, Haiti, Peru, Puerto Rico, Thailand
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaborators

Completed

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

HIV Infections

United States, Puerto Rico
French National Agency for Research on AIDS and...

Terminated

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

HIV Infections

France
Universitätsklinikum Hamburg-Eppendorf

Completed

Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events (IDEAL)

HIV-Infection

Germany
Lund University
Ethiopian Public Health Institute; Armauer Hansen Research Institute, Ethiopia and other collaborators

Recruiting

HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia (THESA)

Antiretroviral Therapy | HIV-1-infection

Ethiopia
South East Asia Research Collaboration with Hawaii
National Institute of Allergy and Infectious Diseases (NIAID); National Institute... and other collaborators

Completed

Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection

Acute HIV Infection | Antiretroviral Treatment Interruption

Thailand
University of Zimbabwe
University Hospital Inselspital, Berne; University of Oxford; Wellcome Trust; University... and other collaborators

Unknown

The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study (UZ-CHS-BC)

HIV Infections | Immune Activation | Comorbidities
UPECLIN HC FM Botucatu Unesp

Unknown

Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy

HIV Infections

Brazil
National Institute of Allergy and Infectious Diseases...

Completed

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

HIV Infections | Hepatitis C

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

HIV Infections

United States
French National Agency for Research on AIDS and...

Completed

Long-Term Supervised Treatment Interruption in HIV-Infected Patients

HIV Infections

France
United BioPharma

Withdrawn

the Study to Evaluate the Safety of UB-421 in Combination With Antiretroviral Therapy (ART) and the Efficacy in Reduction of HIV Viral Load and Proviral DNA as Compared to ART Alone in ART-experienced Viremic HIV-1 Patients

HIV-1 Infection
Genetic Immunity

Completed

Single DermaVir Immunization in HIV-1 Infected Patients on HAART (GIHU004)

HIV Infection

Hungary
French National Agency for Research on AIDS and...
National Institutes of Health (NIH)

Completed

Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)

HIV Infection | Tuberculosis

Cambodia
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID); AIDS Clinical... and other collaborators

Recruiting

Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study

HIV Infection

Malawi, Botswana, South Africa, Zimbabwe
University of California, San Francisco
Chan Zuckerberg Biohub

Recruiting

SCOPE Analytic Treatment Interruption Protocol (SCOPE-ATI)

HIV/AIDS

United States
Mayo Clinic

Enrolling by invitation

Analytic Treatment Interruption (ATI) to Assess HIV Cure

HIV

United States
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID); AIDS Clinical... and other collaborators

Active, not recruiting

Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study

HIV Infection

United States, Peru, Brazil
National Cancer Institute (NCI)

Recruiting

Imaging and Biopsy of HIV-Infected Individuals Undergoing Analytic Treatment Interruption

HIV

United States
Massachusetts General Hospital
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
ANRS, Emerging Infectious Diseases

Completed

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx (ILIADE)

HIV Infections

United States, France
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy

HIV Infections

Botswana, Malawi, Zimbabwe, Brazil
Florida International University
National Institute of Mental Health (NIMH)

Recruiting

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT) (TRIDENT)

Depression | Inflammation | HIV-1-infection

United States
Imperial College London

Recruiting

Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma (STARKAP)

Refractory HIV Associated Kaposi Sarcoma

United Kingdom
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV

HIV Infections | HIV-1-infection | PD-L1 Gene Mutation

China

Search clinical trials for: Antiretroviral Therapy Interruption(ATI)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations